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A B S T R A C T
Meniere’s disease (MD) is a chronic condition affecting the inner ear whose precise etiology is currently un-
known. We propose the hypothesis that MD is a migraine-related phenomenon which may have implications for
future treatment options for both diseases. The association between MD and migraine is both an epidemiological
and a mechanistic one, with up to 51% of individuals with MD experiencing migraine compared to 12% in the
general population. The presence of endolymphatic hydrops in those with MD may be the factor that unites the
two conditions, as hydropic inner ears have an impaired ability to maintain homeostasis. Migraine headaches are
theorized to cause aura and symptoms via spreading cortical depression that ultimately results in substance P
release, alterations in blood flow, and neurogenic inflammation. Chronically hydropic inner ears are less able to
auto-regulate against the changes induced by active migraine attacks and may ultimately manifest as MD. This
same vulnerability to derangements in homeostasis may also explain the common triggering factors of both MD
attacks and migraine headaches, including stress, weather, and diet. Similarly, it may explain the efficacy of
common treatments for both diseases: current migraine treatments such as anti-hypertensives and anti-con-
vulsants have shown promise in managing MD. Though the etiology of both MD and migraine is likely multi-
factorial, further exploration of the association between the two conditions may illuminate how to best manage
them in the future. MD is likely a manifestation of cochleovestibular migraine, which occurs as a result of
migraine related changes in both the cochlea and vestibule.
Introduction
Meniere’s disease (MD) is a chronic illness first described by Prosper
Meniere over 150 years ago that is characterized by a triad of episodic
hearing loss, vertigo, and aural symptoms including aural fullness and
tinnitus. The condition, which primarily affects the inner ear, causes
“attacks” wherein patients experience fluctuating symptomatology
lasting as short as 20min or as long as 24 h. Although diagnostic cri-
teria for the condition classically reference the above triad of symp-
toms, sufferers may also experience nausea/vomiting, gait disturbance,
and headache during these attacks [1]. Eventually, the affected ear may
develop progressive and permanent loss of hearing. The prevalence of
MD may be as high as 190 people per 100,000, representing over
600,000 sufferers in the United States alone; however, the precise
etiology of the disease is not yet known [2].
It was not until 1937, over 70 years after the first descriptions of the
disease, that a pathologic correlate of MD was found. By analyzing
temporal bone specimens during autopsy, researchers were able to
identify endolymphatic hydrops (EH) as a potential marker of MD [3].
Endolymph is a potassium-rich fluid contained within the inner ear that
plays a crucial role in both hearing and balance; when there is too much
endolymph fluid due to over-production or under-resorption, is it re-
ferred to as EH. EH can be broadly divided into categories based on
etiology and presence of symptoms: there exist congenital, acquired,
and idiopathic forms of EH, and each of these can be symptomatic or
asymptomatic [4]. Known causes of EH include congenital malforma-
tions, trauma, surgery, infection, and neoplastic processes, but it can
also be idiopathic, where there is no known cause or inciting event
[5–8]. Recent studies have confirmed the association between idio-
pathic EH and MD [4,9–12]. Rauch et al. performed a blinded study of
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temporal bones and found that all specimens with a clinical diagnosis of
MD had idiopathic EH; however, there were 6 specimens with idio-
pathic EH who had no MD diagnosis [11]. They concluded that their
“…results challenge the dogma that endolymphatic hydrops per se
generates the symptoms of Meniere's syndrome” [11]. It appears that
although sufferers of MD will in all cases have at least one ear with
hydrops, not every individual with EH experiences the symptoms of
MD. This finding has led to the conclusion that there must be another
factor at play that induces those with EH to develop MD.
Multiple hypotheses have been proposed to explain this outlying
factor. Membrane rupture causing contamination of perilymph with
potassium-rich endolymph, mechanical damage by EH, and vascular
phenomena have all at times been theorized to cause MD [3,4,13].
Recent evidence has refuted the hypothesis that potassium intoxication
of perilymph might explain MD, as well as the theory that EH alone is
responsible for MD [10,14,15]. This has led to recent popularization of
the theory that MD may be related to vascular or ischemic conditions
that affect perfusion of the inner ear during attacks. One such condition
is migraine headaches, which appear to have a partly vascular com-
ponent to their manifestation and have been found in close association
with MD [16–19]. In this paper, we propose that MD is indeed related
to the phenomenon that is migraine, and that treatments traditionally
used for migraine headache can be applied to effectively treat MD as
well.
Hypothesis
Our hypothesis posits that MD is in fact a migraine-related phe-
nomenon, with both conditions united by a common unknown, though
potentially vasculogenic or related to spreading cortical depression,
pathophysiology or risk factor that can predispose to development of
both diseases. This common risk factor can cause those with otherwise
asymptomatic EH to develop MD and potentially progressive hearing
loss. This theory helps explain the significant association of MD with
migraine and the similarity of triggering factors in both diseases.
Furthermore, it can help explain the efficacy of current treatments for
MD as well as provide a steppingstone for future management and
treatment options.
Evaluation of the hypothesis
An epidemiological and mechanistic association between Meniere’s disease
and migraine
Though not every individual with MD will experience migraine and
not every individual with migraine will develop MD, there is a sig-
nificant association of MD with migraine headaches. The association of
migraine with MD dates to MD’s origins in 1861, when Prosper Meniere
first described the condition. In addition to the triad of symptoms used
to characterize MD, Meniere also described migraine headaches and
migraine auras occurring in the very same patient population he used to
elucidate the symptoms of MD [20]. Though the prevalence of migraine
symptoms in this historical population is not known, recent studies
have further explored this connection and determined that up to 51% of
MD sufferers also suffer from migraine headaches [21] and that up to
45% of MD patients experience migraine symptoms during an attack
[17]. Familial clustering of migraine and MD has also been found,
supporting a relationship between the two diagnoses [22].
In addition, migraine is associated with inner ear pathologies, in-
cluding vertigo, tinnitus, and even sudden sensorineural hearing loss
[23]. Two disease entities – vestibular migraine and cochlear migraine
– have been proposed that illustrate the interplay between migraine and
inner ear symptoms. Vestibular migraine encompasses migraine and
vertigo symptoms, and cochlear migraine encompasses migraine and
auditory symptoms [24,25]. When experienced together, they form a
symptom complex we term cochleovestibular migraine that is similar in
presentation to MD [25].
The connection is not merely an epidemiological one but a me-
chanistic one as well. As part of a migraine attack, spreading cortical
depression causes release of neuropeptides and cytokines including
calcitonin gene-related peptide and substance P from the trigeminal
ganglion, leading to vasodilation, increased vascular permeability, and
extravasation of plasma [26–28]. This contributes to the neurogenic
inflammation and pain that occurs during the headache phase of a
migraine. Innervation of the cochlea and cochlear blood vessels by
trigeminal nerve fibers has been previously demonstrated, supporting
the notion that vascular effects of migraine can extend to affect the
inner ear as well [29–31]. To add another layer of complexity, the re-
sponse of inner ears with EH to substance P differs from that of non-
hydropic inner ears. Specifically, chronically hydropic inner ears ap-
pear to lose their ability to autoregulate their vasculature and blood
flow, making them more vulnerable to other stress factors such as those
detailed below [32–35]. This could potentially cause those with ex-
isting neuropeptide and vasomotor dysfunction in the trigeminal nerve,
such as in migraine, to manifest MD. In fact, individuals with con-
current migraine and MD appear to have a younger age of onset of MD
and are more likely to experience bilateral hearing loss and aural full-
ness [36].
Specific case studies have also demonstrated a link between mi-
graine and inner ear pathologies. In one case, migraine-associated
vascular changes may have caused inner ear ischemia and EH, ulti-
mately resulting in sensorineural hearing loss and MD-like symptoms
[37]. In another, an individual with migraine-associated hearing loss
was found to have severe bilateral EH [38]. Both migraine and MD have
also been found in association with drop attacks, though the prevalence
of drop attacks is rare in both conditions and sometimes is associated
with neither [39,40]. Vascular factors that play a role in migraine may
indeed predispose to earlier development of MD and manifestation of
more inner ear symptoms.
Meniere’s disease and migraine share similar triggers
In addition to the epidemiologic and mechanistic association of MD
and migraine, both conditions also share common triggering factors,
including stress, weather changes, and dietary intake. Multiple studies
have found an association between stress levels and migraine occur-
rence, which may be related to the observed ability of steroids to in-
crease the frequency of spreading cortical depression events in the
presence of certain genetic mutations [41–43]. This can be extrapolated
to provide an explanation for why physiologic stressors such as acute
illness, poor sleep quality, and new onset pain disorders, among other
things, can provoke or worsen migraine and MD. Fluctuations in es-
trogen may also contribute to spreading cortical depression and thus
both migraine and MD symptoms. Vestibular migraine in particular has
a similar age of onset as MD in the fifth decade of life, and both mi-
graine and vestibular migraine occur more frequently in women
[44,45]. Sudden decreases in estrogen level, such as those that can
occur peri-menopause, can provoke migraine, and certain female mice
in the presence of estrogen have been observed to have faster and more
frequent cortical spreading depression events [46,47]. Weather effects
including low atmospheric pressure, high temperatures, low humidity,
and increased light intensity during summer months have also been
linked to increased migraine frequency [48–51]. Finally, caffeine has
been reported to trigger migraine as well. Similarly, stress and low
atmospheric pressure have been linked to MD attacks [52–54], and
caffeine consumption was associated with a lower age of onset of MD
[55]. To further unite the two diagnoses, strong odors and visual mo-
tion such as driving or watching television have been identified as
triggers for both migraine and MD [21,56]. While alcohol and sodium
restriction have traditionally been recommended in the management of
MD and have shown some efficacy [57], there have yet to be studies
critically evaluating the effect of these specific dietary changes on MD.
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Some studies have failed to show a link between dietary sodium intake
and migraine occurrence, and rather the effect may be from lack of
sufficient water intake or from nitrites, glutamate, or tyramine that may
be found in high-sodium-content foods [42,58,59].
In fact, both tyramine and caffeine are known vasoconstrictors and
hypertensive agents that may be one of the factors to which hydropic
inner ears are more susceptible [60]. Caffeine promotes vasoconstric-
tion and decreased blood flow that normally is compensated for by
adenosine receptors [61]. With Long term use, however, the impaired
autoregulation of blood flow in hydropic ears may prevent adaptation
and allow for easier provocation of both migraine and MD. This may
also explain why fermented, tyramine-containing alcohol could worsen
both conditions, and how abstaining from fermented alcohol and caf-
feine may improve symptomatology.
Treatments traditionally reserved for migraine may help treat Meniere’s
disease
Current migraine treatment options, including both medical and
surgical treatments, have shown success in treating MD and inner ear
symptomatology. Anti-hypertensive drugs including calcium channel
blockers and beta blockers are options for prophylactic treatment of
migraine [62,63]. Other anti-hypertensive diuretics such as carbonic
anhydrase inhibitors and hydrochlorothiazide can be used as treatment
options for MD, though evidence for efficacy varies [57,64,65]. This
may represent the commonality of vascular factors in both migraine
and MD. Furthermore, by controlling diet for compounds that promote
migraine, particularly caffeine, glutamate, and tyramine, and for de-
hydration, migraine and MD symptoms can be reduced [66]. Tricyclic
antidepressants (e.g., nortriptyline) and anti-convulsants such as to-
piramate have been successfully used to manage MD symptoms as well,
most likely through a variety of mechanisms including neuromodula-
tion and inhibition of certain subtypes of carbonic anhydrase enzymes
[67,68]. Oral and parenteral steroids, which may help prevent
spreading cortical depression and the release of inflammatory media-
tors that can affect the inner ear, have also been used to manage both
acute migraine and MD [19,69,70].
Surgical treatment options such as tympanostomy tubes may alle-
viate both MD attacks and inner ear manifestations of migraine by
preventing changes in barometric pressure from triggering acute events.
This treatment has already shown some ability to alleviate vertigo
symptoms in MD and remains effective for approximately 47% of pa-
tients [71–73]. Interestingly, the percentage of migraine sufferers who
report weather as a trigger also falls within the 40–60% range
[48,74,75]. Though the mechanism is not completely understood,
changes in barometric pressure have been demonstrated to provoke
neuropathic pain in rats [76]. If the inner ear is lesioned, changes in
pressure no longer worsen neuropathic pain [77]. This suggests that the
inner ear is profoundly affected by changes in atmospheric pressure,
which are sensed at the tympanic membrane, and may instigate mi-
graine and MD attacks, particularly in those with EH who are already
more susceptible to perturbations in homeostasis. Removal of the
tympanic membrane’s ability to sense pressure by placing a tympa-
nostomy tube can allow for elimination of barometric pressure changes
as a trigger for both conditions.
Migraine’s association with inner ear symptoms may also explain
why treatments traditionally used for migraine have shown effective-
ness when applied to inner ear pathologies: migraine prophylactic
medications have been successfully used to treat aural fullness, post-
stapedectomy-vertigo, and mal de debarquement syndrome [78–80].
Discussion and conclusion
The association between MD and migraine headache suggests an
underlying factor that unites them both; however, the precise etiology
is not yet fully known. Evidence continues to emerge exploring various
contributing factors of both MD and migraine, including spreading
cortical depression, vasculopathies, neuropeptide derangements, hor-
monal interactions, calcium channelopathies, and salt metabolism
[19,81,82]. Though the true cause may be multifactorial, it is likely that
the underlying triggers cause both MD and migraine depending on the
individual, and in the case of MD, those with existing EH may be more
susceptible. Rather than existing as separate conditions, MD and mi-
graine inner ear disorder may instead exist on a continuum (Fig. 1). At
one end are patients with purely vestibular symptoms (e.g., vertigo,
motion sensitivity, imbalance), termed vestibular migraine. At the other
end of the spectrum are patients who have purely cochlear symptoms
(e.g., fluctuating hearing loss, aural pressure, tinnitus, hyperacusis).
The patients who have the combination of both symptoms are patients
with cochleovestibular migraine, or Meniere’s disease.
As of yet, there is no definitive cure for MD, but treatments tradi-
tionally used for migraine have shown promise in improving quality of
life [67]. Through further exploration of the association between mi-
graine and MD, it may be possible to find more effective treatments and
management techniques. Subsequent studies evaluating the treatment
efficacy of dietary changes, the precise link between migraine, cortical
depression, and inner ear pathologies, and, eventually, the pathophy-
siology of migraine itself may better illuminate the relationship be-
tween MD and migraine, potentially revealing how to best manage and
cure MD in the future.
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